Context Therapeutics Inc. (NASDAQ:CNTX) is one of the best penny stocks under $1 to buy now. Earlier in June, Context ...

AB Science's new Phase 3 trial of masitinib for ALS has been cleared to launch in certain European countries, as well as in ...

The Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed and potential first-in-class KX-826 tincture 1.

"Eleva commences Phase I clinical trial for C3G treatment" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Hillhurst Biopharmaceuticals Inc. ("Hillhurst"), a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products based on known inhaled therapeutics, today announced ...

SE (NASDAQ:ARGX) is one of the Best Extremely Profitable Stocks to Buy Right Now. On June 30, argenx SE (NASDAQ:ARGX) ...

VCU Massey Comprehensive Cancer Center is the first site in the United States to be activated in a global Phase 2a clinical ...

The trial demonstrates that a swallowable, low-pill, non-absorbed iron polymer can match or exceed sevelamer in phosphate ...

Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials. Shares of these ...

Abivax shares surged 500% after positive phase 3 results for obefazimod in moderate-to-severe ulcerative colitis. Click here ...

Results from the phase 3 clinical trial of CAN-2409 demonstrated a statistically significant improvement in disease-free survival (DFS), which may redefine treatment approaches for prostate cancer.